panitumumab
amgen,takeda
['paradigm']
dr. yoshino lba1 #asco22: paradigm conclusions 
Oncologist & Chief Medical Science Officer @ASCO #CancerLinQ. Classical/choral music fan ???? https://t.co/GxpBhxmsFj. RT or like may mean I agree; or not. Tweets=only moi